Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
PSCHvsXBIETF Comparison
Invesco S&P SmallCap Health Care ETF (PSCH) and SPDR S&P Biotech ETF (XBI) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. PSCH is less expensive with a Total Expense Ratio (TER) of 0.29%, versus 0.35% for XBI. PSCH is down -6.58% year-to-date (YTD) with -$14M in YTD flows. XBI performs better with 3.65% YTD performance, and -$59M in YTD flows. Run a side-by-side ETF comparison of PSCH and XBI below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
PSCH vs XBI performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PSCH XBI | -4.72%+1.38% | -11.03%+3.11% | -6.58%+3.65% | -2.86%+47.21% | -2.42%+63.16% | -34.70%-13.71% |
| Flows | PSCH XBI | -$12M-$4M | -$15M-$179M | -$14M-$59M | -$33M+$90M | -$168M-$1.64B | -$230M+$1.20B |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PSCH XBI | +18.03%+25.68% | +23.00%+28.04% | +21.45%+27.26% | +22.75%+32.91% |
| Max drawdown | PSCH XBI | -11.08%-8.19% | -13.37%-21.44% | -23.50%-32.94% | -47.23%-57.63% |
| Max drawdown duration | PSCH XBI | 79d48d | 242d141d | 449d331d | 1718d1822d |
PSCH | XBI | |
Last sale 3/12/2026 at 1:30 PM | $39.81 | $122.62 |
| Previous close 03/11/2026 | $41.15 | $126.38 |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
PSCH | XBI | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
PSCH | XBI | |
|---|---|---|
| Last price | $39.81 | $122.62 |
| 1D performance | -3.26% | -2.98% |
| AuM | $124.38 M | $8.10 B |
| E/R | 0.29% | 0.35% |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the PSCH and XBI ETFs performed in 2026?
As of March 11, 2026, PSCH is down -6.58% year-to-date (YTD), while XBI has returned 3.65%. That puts XBI better performer ahead so far this year.
Which ETF is attracting more investor money: PSCH or XBI?
Year-to-date, the PSCH ETF saw -$14M in flows, compared to -$59M for XBI.
Which ETF is more volatile: PSCH or XBI?
Over the past year, PSCH had a volatility of 23%, while XBI experienced 28.04%.
Which ETF is bigger: PSCH or XBI?
As of March 11, 2026, PSCH holds $124.38 M in assets under management (AUM), while XBI manages $8.10 B.
What sectors do the PSCH and XBI ETFs invest in?
PSCH leans toward sectors like Health Care. Meanwhile, XBI focuses on Health Care.
What are the top holdings of the PSCH ETF and XBI ETF?
PSCH top holdings include ARROWHEAD PHARMACEUTICALS INC, KRYSTAL BIOTECH INC and GLAUKOS. XBI holds in its top three: MODERNA INC, MIRUM PHARMACEUTICALS INC and REVOLUTION MEDICINES INC.
Which ETF is more diversified: PSCH or XBI?
PSCH holds 75 securities with 43.5% of its assets in the top 15. XBI has 149 securities and a top 15 weight of 21.6%.
Small-Cap Biotech ETFs: High-Risk, High-Reward Opportunities
Are Biotechnology ETFs In the Midst of a Comeback?
Two biotech ETFs to watch for the rest of 2022 and beyond
Biotech ETFs – Investing in Health Innovation
Active Trader Report: Use of Leveraged & Inverse ETFs Way Up
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
